Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
The inspections concluded with no Form 483 observations or significant critical findings
Solara Active Pharma Sciences has reported total income of Rs. 364.05 crores during the period ended June 30, 2024
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
The launch of Cefepime-Enmetazobactam marks a significant milestone for India's pharmaceutical industry in fight against AMR
This Unit of Shilpa Medicare is engaged in testing biological samples of clinical studies
The facility was inspected from May 7 to May 17, 2024
PEKK is a high-performance polymer family used in aerospace and other demanding markets
The company will now explore a buyer for its manufacturing site and exit in due course
Subscribe To Our Newsletter & Stay Updated
